For his innovation in the production and application of medical isotopes; for advancing the separation and purification of actinides and heavy elements; and for his leadership in the use of alpha emitters to save the lives of cancer patients.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2016 (2)
- (-) 2005 (3)
- (-) 1998 (2)
- (-) 1996 (3)
- (-) 1988 (2)
- (-) 1979 (5)
- (-) 1976 (2)
- 2022 (1)
- 2020 (1)
- 2017 (1)
- 2015 (2)
- 2014 (1)
- 2013 (2)
- 2012 (1)
- 2010 (1)
- 2009 (1)
- 2008 (3)
- 2007 (2)
- 2006 (1)
- 2004 (2)
- 2003 (3)
- 2002 (2)
- 2001 (2)
- 2000 (1)
- 1999 (3)
- 1997 (2)
- 1994 (2)
- 1992 (2)
- 1991 (1)
- 1990 (1)
- 1989 (1)
- 1987 (1)
- 1986 (1)
- 1985 (3)
- 1983 (2)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2016
For his broad scientific contributions and international reputation in aqueous chemistry and geochemistry; for his research into the structure, dynamics, and reactions at fluid–solid interfaces; and for his leadership and service to ORNL and the international scientific community.
2005
For research in the fields of astrophysics and supernova science.
For studies of the electronic structure of molecules, computational chemistry, and high-performance algorithms and computing.
For developments in biomedical engineering and biotechnology, micromechanical devices, and nanoscale imaging and detection.
1998
For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.
For expertise in developing neutron detection technologies used in scientific research and in nuclear weapon and arms control verification.
1996
For pioneering research in ecosystem theory, ecological modeling, error analysis, hierarchy theory, and landscape ecology and for the development of basic applications in risk assessment and regional environmental analysis.
For development of Z-contrast microscopy, which allows the direct imaging of materials at the atomic scale.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards